Table 3

Enzyme kinetics measured for reactions catalyzed by CYP2D6 isoforms in vitro; dextromethorphan O-demethylation, dextromethorphanN-demethylation, codeine O-demethylation, and fluoxetine N-demethylation products were measured

ReactionP450 IsoformKmVmaxV/KNormalized V/K Ratio
mM pmol/pmol P450/min ml/pmol P450/min
DextromethorphanO-demethylationCYP2D6.13.04  ± 0.649.0  ± 0.502.961
CYP2D6.226.3  ± 1.6414.6  ± 0.30.560.19
CYP2D6.1092.1  ± 13.52.6  ± 0.20.0280.01
CYP2D6.1730.7  ± 2.348.6  ± 0.20.280.10
Dextromethorphan N-demethylationCYP2D6.11300  ± 80039  ± 100.031
CYP2D6.22600  ± 70056  ± 90.0230.77
CYP2D6.103500  ± 20048  ± 20.0140.47
CYP2D6.171000  ± 50011  ± 20.010.33
CodeineO-demethylationCYP2D6.1190  ± 306.40  ± 0.250.0341
CYP2D6.2480  ± 505.68  ± 0.170.0120.35
CYP2D6.10N.D.N.D.N.D.
CYP2D6.17860  ± 2201.70  ± 0.170.0020.06
Fluoxetine N-demethylationCYP2D6.12.84  ± 0.350.653  ± 0.0240.231
CYP2D6.24.33  ± 0.360.257  ± 0.0070.0590.26
CYP2D6.1013.4  ± 1.900.056  ± 0.0030.0040.02
CYP2D6.178.31  ± 0.300.281  ± 0.0030.0340.15

All reactions were run in duplicate. Error estimates are based on the best fit of the average values obtained at each point to the Michaelis-Menten equation using nonlinear regression analysis.

    • N.D., none detectable.